
|Articles|May 1, 2005
- Pharmaceutical Executive-05-01-2005
- Volume 0
- Issue 0
TOC
TOC
Advertisement
Articles in this issue
over 21 years ago
Pharm Exec Ad Starsover 21 years ago
Elephant or Specialist?over 21 years ago
Global Report: Iron Fistover 21 years ago
Washington Report: The Pendulum Swingsover 21 years ago
What Does It Take to be a Global Leader in Trainingover 21 years ago
Unleash the Tabletsover 21 years ago
Eisai's New Leadershipover 21 years ago
Superstar Selectionover 21 years ago
TOCover 21 years ago
Professional Persuasion:101Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Beyond Amyloid, Part One (of two): Tau and Microglia Redefine the Alzheimer’s Pipeline
2
What the Peptide Advisory Vote Actually Means: Q&A with James LaValle
3
Hanmi Pharm Enters $2.3 Billion Licensing Agreement with Genentech for HM17321
4
Focusing on Asset Acquisition Over Building a Single Platform Technology
5




